Tenax Therapeutics, Inc.
Pharmaceutical Preparations · Chapel Hill, NC, United States
- PrincipalsChristopher Thomas GiordanoCEOStuart RichChief Medical OfficerThomas McGauleyInterim CFOand 5 more
- CompanyTenax Therapeutics, Inc.Chapel Hill, NC, United States
- Phone line+1 (919) 855-2100General business
Tenax Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker TENX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 8
Chief executive
Chair & board
Declan DooganDirector (Board)
Gerald T ProehlDirector (Board)
June Sherie AlmenoffDirector (Board)
Michael H. DavidsonDirector (Board)
Finance
Thomas McGauleyInterim CFO
Everyone else on file (1)
Stuart RichChief Medical Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Thomas McGauley — Interim CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Stuart Rich — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Declan Doogan — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Christopher Thomas Giordano — CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Xenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capability